The recommended dose of Lodalis Tablets in adults, whether used as monotherapy or in combination with a statin, is 6 tablets once daily or 3 tablets twice daily. Lodalis has not been studied in children younger than 10 years of age or in pre-menarchal girls.Lodalis has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias.Lodalis has not been studied in pediatric patients with type 2 diabetes.Lodalis has not been studied in type 2 diabetes in combination with a dipeptidyl peptidase 4 inhibitor.Lodalis should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis.In addition to glycemic control, intensive lipid control is warranted. Lodalis is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.ĭiabetes mellitus is considered a CHD risk equivalent. The goal for non-HDL-C in persons with high serumTG is set at 30 mg/dL higher than that for LDL-C. In patients with coronary heart disease (CHD) or CHD risk equivalents such as diabetes mellitus, LDLC treatment goals are 200 mg/dL, then non-HDL cholesterol (non-HDL-C) (total cholesterol minus high density lipoprotein cholesterol ) becomes a secondary target of therapy. Lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol whenresponse to diet and non-pharmacological interventions alone has been inadequate. two or more other CVD risk factors are present in the pediatric patient.there is a positive family history of premature cardiovascular disease or.Lodalis is indicated as monotherapy or in combination with a statin to reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: Lodalis is indicated as an adjunct to diet and exercise to reduce elevated low-density lipoproteincholesterol (LDL-C) in adults with primary hyperlipidemia (Fredrickson Type IIa) as monotherapy or in combination with a hydroxymethyl-glutaryl-coenzyme A (HMG CoA) reductase inhibitor (statin).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |